Loading organizations...
Loading organizations...
Rapid, ultra-high multiplex PCR-based target enrichment for NGS.
Paragon Genomics, Inc. has raised $8.0M across 1 funding round.
Paragon Genomics, Inc. has raised $8.0M in total across 1 funding round.
Paragon Genomics, Inc. has raised $8.0M in total across 1 funding round.
Paragon Genomics, Inc.'s investors include Co-win Ventures, Fosun, HEDA Ventures, Wisemont Capital.
Paragon Genomics, Inc. has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Series A in September 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 12, 2017 | $8.0M Series A | Co-win Ventures, Fosun | HEDA Ventures, Wisemont Capital |